drugset / Trial / NCT06365424
Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)
RandomizedParallel-groupOpen-labelTreatment
Summary
An Open Label Long-Term Study to Evaluate the Safety and Effectiveness of Fenofibrate in Subjects with Primary Biliary Cholangitis (PBC)
Timeline
- Start
- 2017-04-08
- Primary completion
- 2027-04
- Completion
- 2027-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fenofibrate | Small molecule | 200 mg | — |
| Subject | Ursodeoxycholic Acid | Small molecule | 13 mg/kg | — |
| Subject | Ursodeoxycholic Acid | Small molecule | 15 mg/kg | — |